← Open Payments lookup

JOHN NJUGUNA: Open Payments

NPI 1184341802 · AMESBURY, MA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$443 in 11 payments from 7 companies in 2025. Trend: 2023 $226 · 2024 $602 · 2025 $443

Food & beverage: $443
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$227
Teva Pharmaceuticals USA, Inc.3$86
Neurocrine BioSciences, Inc.2$41
Lundbeck LLC1$28
ABBVIE INC.1$24
Otsuka America Pharmaceutical, Inc.1$22
Takeda Pharmaceuticals U.S.A., Inc.1$15

Products named: CAPLYTA, UZEDY, REXULTI, INGREZZA, AUSTEDO XR, VRAYLAR, TRINTELLIX.

Industry payments across MA — which companies pay providers there.